Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor (Q43873032)

27 November 2017

title

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor (English)

1 reference

27 November 2017

1 reference

Edward K Geissler

1 reference

27 November 2017

Markus Guba

1 reference

27 November 2017

Philipp von Breitenbuch

1 reference

27 November 2017

Markus Steinbauer

1 reference

27 November 2017

Gudrun Koehl

1 reference

27 November 2017

Stefanie Flegel

1 reference

27 November 2017

Matthias Hornung

1 reference

27 November 2017

Christiane J Bruns

1 reference

27 November 2017

Carl Zuelke

1 reference

27 November 2017

Stefan Farkas

1 reference

27 November 2017

Matthias Anthuber

1 reference

27 November 2017

Karl-Walter Jauch

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

27 November 2017

1 reference

27 November 2017

1 reference

27 November 2017

1 reference

27 November 2017

page(s)

128-135

1 reference

Recurrence of bronchioloalveolar carcinoma in transplanted lungs

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

Liver transplantation for cholangiocarcinoma: results in 207 patients

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

The mechanism of action of cyclosporin A and FK506

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

The incidence of tumours in renal transplant recipients with long-term immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

Mechanisms of coronary angiogenesis in response to stretch: role of VEGF and TGF-beta

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

Angiogenesis in cancer and other diseases

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

Activity of rapamycin (AY-22,989) against transplanted tumors

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

Tumor induction of VEGF promoter activity in stromal cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

The role of vascular endothelial growth factor in pathological angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

p70 S6 kinase-mediated protein synthesis is a critical step for vascular endothelial cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

Identification of tyrosine residues in vascular endothelial growth factor receptor-2/FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: involvement of transforming growth factor beta1.

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

Rapamycin in transplantation: a review of the evidence

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

Differential effects of short-term ace- and AT1-receptor inhibition on postischemic injury and leukocyte adherence in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR

1 reference

https://api.crossref.org/works/10.1038%2FNM0202-128

7 January 2021

Identifiers

DOI

10.1038/NM0202-128

1 reference

Dimensions Publication ID

27 November 2017

1015189512

0 references

1 reference